E. Stacey et al., DECREASED NITRIC-OXIDE LEVELS AND BONE TURNOVER IN AMENORRHEIC ATHLETES WITH SPINAL OSTEOPENIA, The Journal of clinical endocrinology and metabolism, 83(9), 1998, pp. 3056-3061
Amenorrheic athletes have been likened to postmenopausal women, with l
ow estrogen levels and osteopenia. It has been suggested that estrogen
exerts its antiresorptive actions on bone via a nitric oxide (NO)-dep
endent mechanism. This study investigated whether the mechanism of bon
e loss in amenorrheic athletes is similar to that of postmenopausal wo
men with reduced NO levels and high bone turnover. Eleven amenorrheic
athletes, 15 eumenorrheic athletes, and 10 sedentary controls were stu
died. Spine and hip bone mineral density was measured using dual-energ
y x-ray absorptiometry. Bone turnover was assessed by biochemical mark
ers of formation (osteocalcin and bone-specific alkaline phosphatase)
and resorption (deoxypyridinoline). NO metabolites were measured from
24-h urine samples using a chemiluminescence assay. Spine, but not hip
, bone mineral density was reduced in the amenorrheic group, compared
with the eumenorrheic (P = 0.0001) and control (P = 0.04) groups. Oste
ocalcin, bone-specific alkaline phosphatase, and deoxypyridinoline wer
e similar in all groups. NO metabolites were lower in the amenorrheic
group, compared with controls (P = 0.035), despite a higher dietary in
take of nitrates. Unlike postmenopausal women, amenorrheic athletes do
not have raised bone turnover but do have reduced NO metabolites and
spinal osteopenia. The results show, however, that reduced NO producti
on is a common denominator in both conditions and further support the
importance of NO in estrogen-mediated protection of skeletal mass and
strength.